Journal
CURRENT OPINION IN PHARMACOLOGY
Volume 9, Issue 4, Pages 530-534Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2009.06.019
Keywords
-
Categories
Funding
- Asthma UK
- Pfizer Ltd
Ask authors/readers for more resources
Systems biology is being increasingly used to probe the underlying pathophysiology of asthma, although serious challenges remain to decipher the physiologic significance of the information revealed in these studies relating to gene expression and regulatory gene networks often used to understand gene-gene interactions. One phenotypic change characteristic of asthma is increased airway irritability, or bronchial hyperresponsiveness; (BHR) which is still poorly understood. While the precise mechanism(s) remain(s) to be identified, a number of hypotheses have been posited to account for this phenomenon, including airways inflammation, alteration in airway smooth muscle function, and airway remodeling. However, the role of sensory nerves in this phenomenon has received scant attention yet offers a potentially new target for the development of novel drugs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available